Search Results - Alemozaffer, M.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Subgroup analyses of the phase 3 study of intravesical nadofaragene firadenovec in patients with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

    Subgroup analyses of the phase 3 study of intravesical nadofaragene firadenovec in patients with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) by Narayan, V., Boorjian, S., Alemozaffer, M., Konety, B.R., Gomella, L., Kamat, A.M., Lerner, S.P., Svatek, R.S., Karsh, L., Canter, D., Lotan, Y., Inman, B.A., Yang, M., Garcia-Horton, V., Sawutz, D., Parker, N., Dinney, C.P.N.

    Published in European urology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Significant anti-adenovirus antibody response positively correlates with efficacy in patients treated with nadofaragene firadenovec for high-grade BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

    Significant anti-adenovirus antibody response positively correlates with efficacy in patients treated with nadofaragene firadenovec for high-grade BCG-unresponsive Non-Muscle Invas... by Narayan, V., Boorjian, S., Alemozaffer, M., Konety, B.R., Gomella, L., Kamat, A.M., Lerner, S.P., Svatek, R.S., Karsh, L., Canter, D., Lotan, Y., Inman, B.A., Yang, M., Garcia-Horton, V., Sawutz, D., Parker, N., Dinney, C.P.N.

    Published in European urology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: